CMS Overview

CMS is an innovative pharmaceutical company focused on the identification, building, and full lifecycle management of differentiated specialty pharmaceuticals. With a dual-engine approach of in-house R&D and collaborative R&D, and leveraging its core capability to build markets and brands from the ground up, CMS enables each medicine to fully realize both its clinical value and commercial value.

Focusing on unmet clinical needs, CMS efficiently advances the research, clinical development and regulatory approval of differentiated specialty medicines. Drawing on evidence-based medicine and long-standing expertise across specialty therapeutic areas, CMS establishes the medical positioning of its products Through a professional academic promotion system, CMS drives clinical recognition and large-scale application of its products, translating clinical value into enduring brand competitiveness.

CMS focuses on specialty areas including cardiovascular-kidney-metabolic, central nervous system, gastroenterology, ophthalmology, and skin health. It continuously expands its product portfolio, fostering a tiered structure of marketed products and innovative pipeline candidates, and leverages its solid medical expertise and omni-channel commercialization network to drive the growth of new products. Within the Group, its skin health business, Dermavon, has grown into a leading innovative pharmaceutical company in China’s skin health sector. Meanwhile, CMS is expanding its international business with Southeast Asia as a base, advancing product introduction, registration and commercialization in line with local healthcare needs, while progressively optimizing its regional manufacturing footprint to strengthen localized operations and supply capabilities.